국제 저명 저널 연구 성과 (2015-2017년)
국제 저명 저널에 실린 분자병리 관련 연구 성과 (IF 5 이상)
Won JK, Yu SJ, Hwang CY, Cho SH, Park SM, Kim K, Choi WM, Cho H, Cho EJ, Lee JH, Lee KB, Kim YJ, Suh KS, Jang JJ, Kim CY, Yoon JH, Cho KH. Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.Hepatology. 2017 Apr 25. doi: 10.1002/hep.29237.
Bae JM, Kim JH, Kwak Y, Lee DW, Cha Y, Wen X, Lee TH, Cho NY, Jeong SY, Park KJ, Han SW, Lee HS, Kim TY, Kang GH. Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system.Br J Cancer. 2017 Apr 11;116(8):1012-1020.
Kim S, Koh J, Kwon D, Keam B, Go H, Kim YA, Jeon YK, Chung DH. Comparative analysis of PD-L1 expression between primary and metastatic pulmonary adenocarcinomas. Eur J Cancer. 2017 Apr;75:141-149.
Bae JM, Kim JH, Oh HJ, Park HE, Lee TH, Cho NY, Kang GH. Downregulation of acetyl-CoA synthetase 2 is a metabolic hallmark of tumor progression and aggressiveness in colorectal carcinoma. Mod Pathol. 2017 Feb;30(2):267-277.
Kim JH, Park HE, Cho NY, Lee HS, Kang GH. Characterization of PD-L1-positive subsets of microsatellite-unstable colorectal cancers. Br J Cancer 2016 Aug 9;115(4):490-6.
Won JK, Keam B, Koh J, Cho HJ, Jeon YK, Kim TM, Lee SH, Lee DS, Kim DW, Chung DH. Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor. Ann Oncol. 2015 Feb;26(2):348-54.
Kim S, Kim MY, Koh J, Go H, Lee DS, Jeon YK, Chung DH. Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas. Eur J Cancer. 2015 Nov;51(17):2698-707.
Koh J, Go H, Keam B, Kim MY, Nam SJ, Kim TM, Lee SH, Min HS, Kim YT, Kim DW, Jeon YK, Chung DH. Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status. Mod Pathol. 2015 Sep;28(9):1154-66.